Skip to Main Content

Paper Details

A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries.
Cancers (Basel)
10
2020
BIA, BIA-ALCL, BIA-ALCL models, Breast implant-associated lymphoma, IL89, IL89_CL#3488, JAK, JAK1, JAK1 Mutant, JAK1 Mutant Breast, JAK1G1097D, KMT2C, PDGFB, PDGFRA, PTCL, Patient, SETBP1, continuous cell line, differentially expressed genes, human, human primary lymphoma, lymphoma, patient, peripheral T-cell lymphoma, primary lymphoma, primary sample, ruxolitinib, tumor, variant allele
Author NameAffiliation
Paul Zumbo
Zhaoqi LiuColumbia University
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
Robin Fo??Sapienza University of Rome
Raul RabadanColumbia University
David M WeinstockDana-Farber Cancer Institute and Harvard Medical School
Giorgio Inghirami
  • 1 - 7

Datasets

Release 1.2